Literature DB >> 7979530

Natural history of trisomy 13.

J P Wyllie1, M J Wright, J Burn, S Hunter.   

Abstract

The poor prognosis of patients with trisomy 13 has long been accepted and has been ascribed to brain and heart malformations. It has been suggested, however, that the long term survival is better than was previously thought and that cardiac surgery may be justified. This population based study reviews the incidence, antenatal diagnosis, spectrum of survival from congenital heart disease, and mode of death for patients with trisomy 13 in the Northern Health Region from 1985 to 1992. There was an observed prevalence at birth of 0.049/1000 live births and an expected prevalence, allowing for antenatal diagnosis, of 0.077. None of the cardiac lesions found would cause early death. The median survival in this series was four days; the longest survival was 3.5 months. The principal mode of death was apnoea in 14 of 16 children, irrespective of the presence of a cranial abnormality. In the light of these findings, cardiac surgery cannot be justified in patients with trisomy 13.

Entities:  

Mesh:

Year:  1994        PMID: 7979530      PMCID: PMC1030016          DOI: 10.1136/adc.71.4.343

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Rates and survival of individuals with trisomy 13 and 18. Data from a 10-year period in Denmark.

Authors:  H Goldstein; K G Nielsen
Journal:  Clin Genet       Date:  1988-12       Impact factor: 4.438

2.  Outbreak of toxic epidermal necrolysis associated with staphylococci.

Authors:  A Lyell; H M Dick; J O Alexander
Journal:  Lancet       Date:  1969-04-19       Impact factor: 79.321

3.  Trisomy 13 (D1) syndrome: studies on parental age, sex ratio, and survival.

Authors:  R E Magenis; F Hecht; S Milham
Journal:  J Pediatr       Date:  1968-08       Impact factor: 4.406

4.  Frequency and occurrence of chromosomal syndromes. I. D-Trisomy.

Authors:  P E Conen; B Erkman
Journal:  Am J Hum Genet       Date:  1966-07       Impact factor: 11.025

5.  Screening for congenital heart disease prenatally. Results of a 2 1/2-year study in the South East Thames Region.

Authors:  G K Sharland; L D Allan
Journal:  Br J Obstet Gynaecol       Date:  1992-03

Review 6.  Trisomy 13 (Patau syndrome) with an 11-year survival.

Authors:  B Zoll; J Wolf; D Lensing-Hebben; M Pruggmayer; B Thorpe
Journal:  Clin Genet       Date:  1993-01       Impact factor: 4.438

7.  Long survival in trisomy-13-syndrome: 21 cases including prolonged survival in two patients 11 and 19 years old.

Authors:  R Redheendran; R L Neu; R M Bannerman
Journal:  Am J Med Genet       Date:  1981

8.  Echocardiographic evaluation of the spectrum of cardiac anomalies associated with trisomy 13 and trisomy 18.

Authors:  N N Musewe; D J Alexander; I Teshima; J F Smallhorn; R M Freedom
Journal:  J Am Coll Cardiol       Date:  1990-03-01       Impact factor: 24.094

9.  Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk.

Authors:  B J Baty; B L Blackburn; J C Carey
Journal:  Am J Med Genet       Date:  1994-01-15

10.  Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age.

Authors:  E B Hook
Journal:  Am J Hum Genet       Date:  1983-01       Impact factor: 11.025

View more
  20 in total

Review 1.  Cyclopia: an epidemiologic study in a large dataset from the International Clearinghouse of Birth Defects Surveillance and Research.

Authors:  Iêda M Orioli; Emmanuelle Amar; Marian K Bakker; Eva Bermejo-Sánchez; Fabrizio Bianchi; Mark A Canfield; Maurizio Clementi; Adolfo Correa; Melinda Csáky-Szunyogh; Marcia L Feldkamp; Danielle Landau; Emanuele Leoncini; Zhu Li; R Brian Lowry; Pierpaolo Mastroiacovo; Margery Morgan; Osvaldo M Mutchinick; Anke Rissmann; Annukka Ritvanen; Gioacchino Scarano; Elena Szabova; Eduardo E Castilla
Journal:  Am J Med Genet C Semin Med Genet       Date:  2011-10-17       Impact factor: 3.908

2.  Neuroradiological findings of trisomy 13 in a rare long-term survivor.

Authors:  Ryan D Goff; Bruno P Soares
Journal:  Neuroradiol J       Date:  2017-02-14

3.  Natural history of trisomy 18.

Authors:  N D Embleton; J P Wyllie; M J Wright; J Burn; S Hunter
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-07       Impact factor: 5.747

4.  Pediatric sub-specialist controversies in the treatment of congenital heart disease in trisomy 13 or 18.

Authors:  Andrew R Yates; Timothy M Hoffman; Edward Shepherd; Bethany Boettner; Kim L McBride
Journal:  J Genet Couns       Date:  2011-05-18       Impact factor: 2.537

5.  Major anomalies and birth-weight influence NICU interventions and mortality in infants with trisomy 13 or 18.

Authors:  K Acharya; S Leuthner; R Clark; T H Nghiem-Rao; A Spitzer; J Lagatta
Journal:  J Perinatol       Date:  2017-01-12       Impact factor: 2.521

6.  Major chromosomal anomalies among very low birth weight infants in the Vermont Oxford Network.

Authors:  Nansi S Boghossian; Jeffrey D Horbar; Joseph H Carpenter; Jeffrey C Murray; Edward F Bell
Journal:  J Pediatr       Date:  2011-12-16       Impact factor: 4.406

7.  Long-Term Outcomes of Children With Trisomy 13 and 18 After Congenital Heart Disease Interventions.

Authors:  Jennifer K Peterson; Lazaros K Kochilas; Kirsti G Catton; James H Moller; Shaun P Setty
Journal:  Ann Thorac Surg       Date:  2017-04-26       Impact factor: 4.330

8.  Gestational, perinatal and family findings of patients with Patau syndrome.

Authors:  Rafael Fabiano M Rosa; Melina Vaz Sarmento; Janaina Borges Polli; Daniela de Paoli Groff; Patrícia Petry; Vinícius Freitas de Mattos; Rosana Cardoso M Rosa; Patrícia Trevisan; Paulo Ricardo G Zen
Journal:  Rev Paul Pediatr       Date:  2013-12

9.  Better prognosis in newborns with trisomy 13 who received intensive treatments: a retrospective study of 16 patients.

Authors:  Keiko Tsukada; George Imataka; Hiroshi Suzumura; Osamu Arisaka
Journal:  Cell Biochem Biophys       Date:  2012-07       Impact factor: 2.194

10.  Mortality and morbidity of VLBW infants with trisomy 13 or trisomy 18.

Authors:  Nansi S Boghossian; Nellie I Hansen; Edward F Bell; Barbara J Stoll; Jeffrey C Murray; John C Carey; Ira Adams-Chapman; Seetha Shankaran; Michele C Walsh; Abbot R Laptook; Roger G Faix; Nancy S Newman; Ellen C Hale; Abhik Das; Leslie D Wilson; Angelita M Hensman; Cathy Grisby; Monica V Collins; Diana M Vasil; Joanne Finkle; Deanna Maffett; M Bethany Ball; Conra B Lacy; Rebecca Bara; Rosemary D Higgins
Journal:  Pediatrics       Date:  2014-01-20       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.